Document Detail


Prolonged beneficial effects of dobutamine in refractory heart failure--case histories.
MedLine Citation:
PMID:  3631648     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two patients with refractory congestive heart failure were treated with dobutamine for forty-eight to seventy-two hours with close monitoring of weight and symptomatology. After two to four cycles of dobutamine treatment, 1 patient showed sustained hemodynamic benefit after six months, whereas the second patient had partial improvement. At the end of a one-year follow-up, both had sustained improvement in effort tolerance, documented by a stress test. The quality of life has markedly improved, and they have not required further hospital care.
Authors:
B Puram; J Margolis; V Puram
Related Documents :
6497518 - Nonarrhythmogenicity of diuretic-induced hypokalemia. its evidence in patients with unc...
18760668 - Long term vagal stimulation in patients with advanced heart failure: first experience i...
15880338 - Symptoms in patients with heart failure are prognostic predictors: insights from comet.
16919008 - First experience with an oral combination therapy using bosentan and sildenafil for pul...
24404878 - Effects of photoperiod on broodiness, egg-laying and endocrine responses in native layi...
16899528 - Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-ye...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Angiology     Volume:  38     ISSN:  0003-3197     ISO Abbreviation:  Angiology     Publication Date:  1987 Aug 
Date Detail:
Created Date:  1987-10-19     Completed Date:  1987-10-19     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0203706     Medline TA:  Angiology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  631-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Dobutamine / administration & dosage,  therapeutic use*
Follow-Up Studies
Heart Failure / drug therapy*,  physiopathology
Hemodynamics
Humans
Male
Middle Aged
Time Factors
Chemical
Reg. No./Substance:
34368-04-2/Dobutamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Right atrial thrombus and recurrent pulmonary emboli secondary to permanent cardiac pacing--a case r...
Next Document:  Communicating hydrocephalus as a complication of isolated CNS angiitis--a case report.